The Effects of Ramipril in Individuals at Risk for Alzheimer’s Disease: Results of a Pilot Clinical Trial

Research shows that certain antihypertensives taken during midlife confer Alzheimer’s disease (AD) related benefits in later life. We conducted a clinical trial to evaluate the extent to which the angiotensin converting enzyme inhibitor (ACE-I), ramipril, affects AD biomarkers including CSF amyloid...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Wharton, Whitney, Stein, James H., Korcarz, Claudia, Sachs, Jane, Olson, Sandra R., Zetterberg, Henrik, Dowling, Maritza, Ye, Shuyun, Gleason, Carey E., Underbakke, Gail, Jacobson, Laura E., Johnson, Sterling C., Sager, Mark A., Asthana, Sanjay, Carlsson, Cynthia M.
Formato: Artigo
Idioma:Inglês
Publicado em: 2012
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3593582/
https://ncbi.nlm.nih.gov/pubmed/22776970
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/JAD-2012-120763
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados